STEPHEN ROCAMBOLI

Insider Reports History

Location
New York, NY
Signature
/s/ Sheldon L. Koenig, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by STEPHEN ROCAMBOLI:

Company Role Class Num Shares Value Price $ Report Date Ownership
Esperion Therapeutics, Inc. Director Common Stock 69,261 $55,408 $0.8000 29 May 2025 Direct
Esperion Therapeutics, Inc. Director Stock Option (right to buy) 44,000 $52,650 $1.62 29 May 2025 Direct
TFF Pharmaceuticals, Inc. Director Common Stock 39,165 $15,337 $0.3916 03 Jul 2024 Direct
TFF Pharmaceuticals, Inc. Director Restricted stock units 4,667 $1,828 $0.3916 18 Apr 2024 Direct
TFF Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 3,165 03 Jul 2024 Direct

Insider Reports Filed by STEPHEN ROCAMBOLI

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ESPR Esperion Therapeutics, Inc. 29 May 2025 2 $0 4 Director 02 Jun 2025, 16:08
TFFP TFF Pharmaceuticals, Inc. 03 Jul 2024 2 $0 4 Director 08 Jul 2024, 17:41
ESPR Esperion Therapeutics, Inc. 23 May 2024 2 $0 4 Director 24 May 2024, 16:15
TFFP TFF Pharmaceuticals, Inc. 18 Apr 2024 1 $0 4 Director 22 Apr 2024, 20:48
TFFP TFF Pharmaceuticals, Inc. 01 Dec 2023 1 $0 4 Director 04 Dec 2023, 17:29
TFFP TFF Pharmaceuticals, Inc. 15 Aug 2023 1 +$5,000 4 Director 15 Aug 2023, 09:00
ESPR Esperion Therapeutics, Inc. 15 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:06
ESPR Esperion Therapeutics, Inc. 10 May 2023 1 +$12,126 4 Director 11 May 2023, 16:10
TFFP TFF Pharmaceuticals, Inc. 10 Mar 2023 1 +$10,432 4 Director 13 Mar 2023, 16:22
TFFP TFF Pharmaceuticals, Inc. 29 Dec 2022 1 $0 4 Director 30 Dec 2022, 15:55
ESPR Esperion Therapeutics, Inc. 26 May 2022 2 $0 4 Director 27 May 2022, 16:13
TFFP TFF Pharmaceuticals, Inc. 16 May 2022 1 +$13,620 4 Director 17 May 2022, 21:50
ESPR Esperion Therapeutics, Inc. 28 Apr 2022 0 $0 3 Director 28 Apr 2022, 16:37